Form 4: BNY Mellon Director Rakefet Russak-Aminoach Receives Grant

Director Rakefet Russak-Aminoach was granted 1,592 deferred stock units by The Bank of New York Mellon Corp.

Summary

• Director Rakefet Russak-Aminoach acquired 1,592 deferred stock units on April 17, 2026.
• The units are granted on a 1-for-1 basis relative to common stock.
• The units vest on the earlier of the 2027 Annual Meeting of Shareholders or one year from the grant date.
• Following this transaction, the director holds a total of 8,305.601 units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which carries a neutral sentiment.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Value of deferred stock units is subject to market fluctuations in BNY Mellon common stock price.

Future Outlook

The deferred stock units are scheduled to vest in 2027, with payout occurring upon the director's termination of service, subject to the director's election of lump sum or installment payments.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the financial services sector to ensure directors maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant of deferred stock units is consistent with standard director compensation packages at large-cap financial institutions like JPMorgan Chase, Citigroup, and State Street.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the 1,592 deferred stock units at the 2027 Annual Meeting or one year from the grant date.

Key Dates

Keywords

BNY Mellon, BK, Director Compensation, Form 4, Insider Trading, Equity Grant